Some people with early stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab, ...

New cancer research pioneered by Memorial Sloan Kettering points to a strong alternative to chemotherapy ... according to a new study. Getty Images This therapy “unmasks” tumor cells, MSK stated, ...

Michael Wolff was at the "edge of a cliff" when he was diagnosed with a cancer that affects less than 300 patients a year in ...

Thanks to our powerful combination of clinical and scientific resources focused exclusively on cancer, Memorial Sloan Kettering is in a unique position ... elements derived from pathology and ...

Hartford (Conn.) HealthCare has opened a new cancer center in partnership with New York City-based Memorial Sloan Kettering Cancer Center. Through the partnership, physicians at the Hartford ...

But Knolmayer learned his cancer had an unusual genetic trait that made him eligible for an experimental trial at Memorial Sloan Kettering Cancer Center in New York. Over six months, he had nine ...

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

Our trainees and students join a vibrant community that includes graduate students, postdocs, medical students, and clinical fellows from across the larger Memorial Sloan Kettering campus. A full ...